June 22, 2010
Kevin Volpp, MD, PhD, investigator at HSR&D's Center for Health Equity Research and Promotion, was recently featured in The New York Times, regarding the role of cash incentives and medication compliance. Dr. Volpp was leading a unique project in which certain patients who have been prescribed warfarin participate in a program that offers cash incentives for medication adherence.
Results of the project showed that a daily lottery-based financial incentive did show potential for improving medication adherence, and investigators suggest that additional testing be done using this approach to determine its effectiveness and potential further application to warfarin, as well as other medications used to treat chronic disease.
The full text of The New York Times article discussing this project is available here. The study results and abstract are also available online, and can be found at BioMedCentral.
